Recorded back in the summer our final episode of 'Scale ups and downs' breaks ground with two founders in the healthtech sphere - Charlotte Guzzo and Julia Fan Li, as we talk about tech, product prioritisation and machine learning optimisations. Alongside Marta and our two brilliant founders we hear from Eric Collins; founder of Impact X, tech-expert and AI evangelist. Also here to impart his wisdom is ex-Google Health, now SVP at Optum, Dominic King. Expect a deep dive into optimised machine learning, prioritising your product vs your platform and some tips on where innovation in this space could be made.

Founders Charlotte Guzzo (Sano Genetics) and Julia Fan Li (Microbiographica Bio) respectively ask:

Should there be more focus and emphasis on the data problem than on the algorithm development?
How do founders/entrepreneurs allocate capital between platform and ultimate product?

For more info from our panel, please follow their social handles:
Eric Collins and Dominic King

And for more information about what our founders are creating, please visit:
Charlotte Guzzo and Sano Genetics
Julia Fan Li and Microbiographica Bio

Scale Ups and Downs

Google for Startups

Product and Innovation: How to prioritise your product vs your platform

OCT 17, 202244 MIN
Scale Ups and Downs

Product and Innovation: How to prioritise your product vs your platform

OCT 17, 202244 MIN

Description

Recorded back in the summer our final episode of 'Scale ups and downs' breaks ground with two founders in the healthtech sphere - Charlotte Guzzo and Julia Fan Li, as we talk about tech, product prioritisation and machine learning optimisations. Alongside Marta and our two brilliant founders we hear from Eric Collins; founder of Impact X, tech-expert and AI evangelist. Also here to impart his wisdom is ex-Google Health, now SVP at Optum, Dominic King. Expect a deep dive into optimised machine learning, prioritising your product vs your platform and some tips on where innovation in this space could be made.

Founders Charlotte Guzzo (Sano Genetics) and Julia Fan Li (Microbiographica Bio) respectively ask:

Should there be more focus and emphasis on the data problem than on the algorithm development?
How do founders/entrepreneurs allocate capital between platform and ultimate product?

For more info from our panel, please follow their social handles:
Eric Collins and Dominic King


And for more information about what our founders are creating, please visit:
Charlotte Guzzo and Sano Genetics
Julia Fan Li and Microbiographica Bio